Refine by:
-
Register for NAMI’s Ask the Expert Webinar: New Horizons in Schizophrenia Research
Register for NAMI's Ask the Expert Webinar: New Horizons in Schizophrenia Research on Thursday, October 8, 2020 at 4:00 p.m. ET. -
Congress Passes New Bill to Improve Veterans’ Mental Health Care
On Wednesday, September 23, 2020, NAMI celebrated the U.S. House of Representatives’ unanimous passage of a landmark bipartisan bill, S. 785, The Commander John Scott Hannon Veterans Mental Health Care Improvement Act. -
NAMI Applauds Victory for Veterans’ Mental Health
Today, the U.S. House of Representatives unanimously passed a landmark bipartisan bill, S. 785, The Commander John Scott Hannon Veterans Mental Health Care Improvement Act, which previously passed the Senate. -
NAMI Joins Public–Private Partnership to Advance Early Interventions for Schizophrenia
Today, NAMI announced it has joined the Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ), which brings together NIH, the U.S. Food and Drug Administration and multiple non-profit and private organizations to work toward meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. -
NAMI Joins Seven Leading Organizations to Launch Mental Health for US Coalition
NAMI, along with other prominent mental health and addiction organizations, launched Mental Health for US: a nonpartisan educational coalition aimed at elevating mental health issues on the 2020 campaign trail. -
Substance Use Carries Mental Health Risks—Yes, Even Marijuana
"We know serious mental illness and substance use disorders often co-occur. And I believe there is room for researching the medical potential of marijuana’s components. But pretending that marijuana is a harmless substance is not the way to help our loved ones." -
NAMI Releases Parity Report Which Finds Insurance Companies Still Discriminate Against Mental Health Care
A report released today by NAMI reveals new information about the ongoing barriers people with mental illness experience when trying to find affordable, quality mental health care. -
FDA Approves Medications for Tardive Dyskinesia
Tardive dyskinesia (TD) had no effective treatment options until this year. The FDA fast-tracked two medications through their approval process, given the unmet medical need for treatment. If you have TD, these medications might be worth a fresh conversation with your prescriber. -
Taking Another Look a Too-Often-Forgotten Treatment for Schizophrenia
We don’t endorse specific treatments at NAMI, but in my role as medical director, I always like to remind people about clozapine. The consensus in the medical community is that, generally speaking, it is an underutilized treatment.
-
Understanding Psychotic Breaks
Psychosis is a complex mental health symptom that over 100,000 young people experience each year. Understand what causes psychosis, how to identify symptoms and how to support someone who may be experiencing it.